MX2022011238A - Combinaciones de compuestos beta-lactamicos, probenecid y acido valproico y sus usos. - Google Patents
Combinaciones de compuestos beta-lactamicos, probenecid y acido valproico y sus usos.Info
- Publication number
- MX2022011238A MX2022011238A MX2022011238A MX2022011238A MX2022011238A MX 2022011238 A MX2022011238 A MX 2022011238A MX 2022011238 A MX2022011238 A MX 2022011238A MX 2022011238 A MX2022011238 A MX 2022011238A MX 2022011238 A MX2022011238 A MX 2022011238A
- Authority
- MX
- Mexico
- Prior art keywords
- combinations
- probenecid
- valproic acid
- beta
- lactam compounds
- Prior art date
Links
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 title abstract 3
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003081 probenecid Drugs 0.000 title abstract 2
- 229960000604 valproic acid Drugs 0.000 title abstract 2
- -1 beta-lactam compounds Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
La presente descripción se relaciona con combinaciones de ácido valproico o una sal farmacéuticamente aceptable del mismo, un compuesto ß-lactámico o una sal farmacéuticamente aceptable del mismo y probenecid o una sal farmacéuticamente aceptable del mismo; la presente descripción también se relaciona con métodos para tratar o prevenir una enfermedad usando las combinaciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062987963P | 2020-03-11 | 2020-03-11 | |
PCT/EP2021/056210 WO2021180857A1 (en) | 2020-03-11 | 2021-03-11 | Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011238A true MX2022011238A (es) | 2022-10-07 |
Family
ID=74871410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011238A MX2022011238A (es) | 2020-03-11 | 2021-03-11 | Combinaciones de compuestos beta-lactamicos, probenecid y acido valproico y sus usos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210283112A1 (es) |
EP (1) | EP4117645A1 (es) |
JP (1) | JP2023517919A (es) |
KR (1) | KR20220152261A (es) |
CN (1) | CN115190797A (es) |
AU (1) | AU2021235058A1 (es) |
BR (1) | BR112022015925A2 (es) |
CA (1) | CA3169900A1 (es) |
MX (1) | MX2022011238A (es) |
WO (1) | WO2021180857A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
RU2499592C2 (ru) * | 2008-04-21 | 2013-11-27 | Отономи, Инк. | Фармацевтическая композиция для лечения ушных заболеваний |
EP3427729A1 (en) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
-
2021
- 2021-03-11 WO PCT/EP2021/056210 patent/WO2021180857A1/en unknown
- 2021-03-11 JP JP2022554381A patent/JP2023517919A/ja active Pending
- 2021-03-11 AU AU2021235058A patent/AU2021235058A1/en active Pending
- 2021-03-11 BR BR112022015925A patent/BR112022015925A2/pt unknown
- 2021-03-11 US US17/198,335 patent/US20210283112A1/en active Pending
- 2021-03-11 MX MX2022011238A patent/MX2022011238A/es unknown
- 2021-03-11 KR KR1020227034566A patent/KR20220152261A/ko unknown
- 2021-03-11 CN CN202180020106.6A patent/CN115190797A/zh active Pending
- 2021-03-11 CA CA3169900A patent/CA3169900A1/en active Pending
- 2021-03-11 EP EP21711548.4A patent/EP4117645A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2021235058A1 (en) | 2022-09-01 |
BR112022015925A2 (pt) | 2022-10-04 |
CN115190797A (zh) | 2022-10-14 |
JP2023517919A (ja) | 2023-04-27 |
EP4117645A1 (en) | 2023-01-18 |
KR20220152261A (ko) | 2022-11-15 |
CA3169900A1 (en) | 2021-09-16 |
US20210283112A1 (en) | 2021-09-16 |
WO2021180857A1 (en) | 2021-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20220354A (es) | Inhibidores de egfr | |
MX2022015207A (es) | Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus. | |
CR20220363A (es) | Compuestos tricíclicos sustituidos | |
MX2022000244A (es) | Pirrolo[2,3-b]pirazinas como inhibidores de hpk1 y uso de las mismas. | |
CR20220312A (es) | Compuestos tricíclicos sustituidos | |
MX2022000271A (es) | Inhibidores de la quinasa progenitora hematopoyetica 1 y usos de los mismos. | |
MX2022006663A (es) | Compuesto heterociclico que contiene oxigeno, metodo de preparacion de este y uso de este. | |
MX2021011606A (es) | Compuestos dirigidos a prmt5. | |
AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
MX2021015854A (es) | Composiciones y métodos para tratar trastornos del snc. | |
MX2021012105A (es) | Compuestos de pirrol. | |
MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
MX2021013531A (es) | Inhibidores de cdk. | |
MX2019006612A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta). | |
MX2023009037A (es) | Compuesto de pirimidopirano. | |
CR20230052A (es) | Combinaciones para el tratamiento de cáncer. | |
MX2021009755A (es) | Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos. | |
PH12019500849A1 (en) | Naphthyridinone derivatives and their use inthe treatment of arrhythmia | |
MX2020002630A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta. | |
WO2020251871A3 (en) | Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors | |
MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
MX2021009717A (es) | Sulfonamidas biciclicas. | |
MX2019008728A (es) | Compuestos de amida y su uso. | |
MX2022011238A (es) | Combinaciones de compuestos beta-lactamicos, probenecid y acido valproico y sus usos. | |
JOP20210319A1 (ar) | مركبات بيروليدين |